Testing effectiveness (Phase 2)Ended earlyNCT03979638
What this trial is testing
A Dose Escalation Study of BLU-5937 in Unexplained or Refractory Chronic Cough
Who this might be right for
Chronic Refractory Cough
Bellus Health Inc. - a GSK company 68